Polymorphisms in the p53 pathway

Oncogene

Volumn 25, Issue 11, 2006, Pages 1602-1611

  Pietsch, E C ^a   Humbey, O ^a   Murphy, M E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Apoptosis; MDM2; p21 waf1; p53; Polymorphism

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN MDM2; PROTEIN P53;

APOPTOSIS; CANCER; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE ARREST; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; MICE; NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645117454     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209367     Document Type: Review

References (134)

1. Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE et al. (2005). J Biol Chem 280: 26776-26787.
2. Bahl R, Arora S, Nath N, Mathur M, Shukla NK, Ralhan R. (2000). Oncogene 19: 323-328.
3. Bastiaens MT, Struyk L, Tjong-A-Hung SP, Gruis N, ter Huurne J, Westendorp RG et al. (2001). Mol Carcinog 30: 56-61.
4. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A et al. (1994). Hum Hered 44: 266-270.
5. Bhatia K, Fan S, Spangler G, Weintraub M, O'Connor PM, Judde JG et al. (1995). Cancer Res 55: 1431-1435.
6. Birgander R, Sjalander A, Saha N, Spitsyn V, Beckman L, Beckman G. (1996). Hum Hered 46: 148-154.
7. Biro E, Kalina I, Salagovic J, Habalova V, Hriv ak M, Valansky L. (2000). Neoplasma 47: 303-306.
8. Biros E, Kalina I, Kohut A, Stubna J, Salagovic J. (2001). Lung Cancer 31: 157-162.
9. Biros E, Kohut A, Biros I, Kalina I, Bogyiova E, Stubna J. (2002). Lung Cancer 35: 231-235.
10. Bonafe M, Ceccarelli C, Farabegoli F, Santini D, Taffurelli M, Barbi C et al. (2003). Clin Cancer Res 9: 4860-4864.
11. Bonafe M, Salvioli S, Barbi C, Mishto M, Trapassi C, Gemelli C et al. (2002). Biochem Biophys Res Commun 299: 539-541.
12. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC et al. (2004). Cell 119: 591-602.
13. Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L et al. (2005). J Med Genet October 28; [Epub: ahead of print].
14. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ. (1995). Nature 377: 552-557.
15. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E et al. (1999). EMBO J 18: 6845-6854.
16. Buyru N, Tezol A, Dalay N. (2005). Anticancer Res 25: 2767-2769.
17. Buyru N, Tigli H, Dalay N. (2003). Oncol Rep 10: 711-714.
18. Chedid M, Michieli P, Lengel C, Huppi K, Givol D. (1994). Oncogene 9: 3021-3024.
19. Chen J, Jackson PK, Kirschner MW, Dutta A. (1995). Nature 374: 386-388.
20. Chen WC, Wu HC, Hsu CD, Chen HY, Tsai FJ. (2002). Urol Oncol 7: 63-66.
21. Chen YC, Xu L, Guo YL, Su HJ, Hsueh YM, Smith TJ et al. (2003). J Environ Sci Health A Tox Hazard Subst Environ Eng 38: 201-211.
22. Cobrinik D. (2005). Oncogene 24: 2796-2809.
23. de Oliveira WR, Rady PL, Grady J, Hughes TK, Neto CF, Rivitti EA et al. (2004). Int J Dermatol 43: 489-493.
24. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P. (1995). Cell 82: 675-684.
25. Deshpande A, Sicinski P, Hinds PW. (2005). Oncogene 24: 2909-2915.
26. Dokianakis DN, Koumantaki E, Billiri K, Spandidos DA. (2000). Int J Mol Med 5: 405-409.
27. Dumont P, Leu JI, Della Pietra III AC, George DL, Murphy M. (2003). Nat Genet 33: 357-365.
28. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). Cell 19: 817-825.
29. Facher EA, Becich MJ, Deka A, Law JC. (1995). Cancer 79: 2424-2429.
30. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK et al. (2000). Cancer Epidemiol Biomarkers Prev 9: 1037-1042.
31. Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC. (1993). Am J Hum Genet 3: 752-759.
32. Fiszer-Maliszewska L, Kazanowska B, Kusnierczyk P, Manczak M, Niepieklo W, Pochron-Zeman B et al. (2003). J Appl Genet 44: 547-552.
33. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ et al. (1994). Proc Natl Acad Sci USA 91: 8655.
34. Gao X, Chen YQ, Wu N, Grignon DJ, Sakr W, Porter AT et al. (1995). Oncogene 11: 1395-1398.
35. Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutierrez-Enriquez S et al. (2004). Oncogene 23: 1954-1956.
36. Gong JZ, Zhou H, Hu Z, Schulman P, Vinceguerra V, Broome JD et al. (1995). Hematol Pathol 9: 171-177.
37. Gottschlich S, Maune S, Preugschat J, Hoffmann M, Werner JA, Maass JD et al. (2000). Anticancer Res 20: 2613-2616.
38. Granja F, Morari J, Morari EC, Correa LA, Assumpcao LV, Ward LS. (2004). Cancer Lett 210: 151-157.
39. Gu Y, Turck CW, Morgan DO. (1993). Nature 366: 707-710.
40. Hachiya T, Kuriaki Y, Ueoka Y, Nishida J, Kato K, Wake N. (1999). Gynecol Oncol 72: 187-192.
41. Harima Y, Sawada S, Nagata K, Sougawa M, Ostapenko V, Ohnishi T. (2001). Int J Mol Med 7: 261-264.
42. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. (1993). Cell 75: 805-816.
43. Harris N, Brill E, Shohat O, Prokocimer M, Wolf D, Arai N et al. (1986). Mol Cell Biol 6: 4650-4656.
44. Harris CC, Hollstein MC. (1993). N Engl J Med 329: 1318-1327.
45. Henner WD, Evans AJ, Hough KM, Harris EL, Lowe BA, Beer TM. (2001). Prostate 49: 263-266.
46. Hillebrandt S, Streffer C, Demidchik EP, Biko J, Reiners C. (1997). Mutat Res 381: 201-207.
47. Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ et al. (2004). Cancer Epidemiol Biomarkers Prev 13: 2217-2224.
48. Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S et al. (1994). Oncogene 9: 3017-3020.
49. Jin S, Levine AJ. (2001). J Cell Sci 114: 4139-4140.
50. Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. (2004). Clin Cancer Res 10: 5845-5849.
51. Kang S, Duan LH, Zhang JH, Guo W, Wang N, Li Y. (2004). Zhonghua Fu Chan Ke Za Zhi 39: 754-758 (Chinese).
52. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M et al. (2000). Cancer Res 60: 2753-2755.
53. Keshava C, Frye BL, Wolff MS, McCanlies EC, Weston A. (2002). Cancer Epidemiol Biomarkers Prev 11: 127-130.
54. Khaliq S, Hameed A, Khaliq T, Ayub Q, Qamar R, Mohyuddin A et al. (2000). Genet Test 4: 23-29.
55. Khrunin AV, Tarskaia LA, Spitsyn VA, Lylova OI, Bebyakova NA, Mikulich AI et al. (2005). Mol Genet Genomics 272: 666-672.
56. Kibel AS, Suarez BK, Belani J, Oh J, Webster R, Brophy-Ebbers M et al. (2003). Cancer Res 63: 2033-2036.
57. Klug SJ, Wilmotte R, Santos C, Almonte M, Herrero R, Guerrero I et al. (2001). Cancer Epidemiol Biomarkers Prev 10: 1009-1012.
58. Konishi R, Sakatani S, Kiyokane K, Suzuki K. (2000). J Dermatol Sci 24: 177-183.
59. Koopmann J, Maintz D, Schild S, Schramm J, Louis DN, Wiestler OD et al. (1995). Br J Cancer 72: 1230-1233.
60. Koushik A, Platt RW, Franco EL. (2004). Cancer Epidemiol Biomarkers Prev 13: 11-22. Review.
61. Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T. (2003). Cancer Lett 189: 77-83.
62. Langerod A, Bukholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO et al. (2002). Cancer Epidemiol Biomarkers Prev 11: 1684-1688.
63. Law JC, Deka A. (1995). Hum Genet 95: 459-460.
64. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S et al. (2000). Cancer Res 60: 1062-1069.
65. Leu JI, Dumont P, Hafey M, Murphy ME, Georges DL. (2004). Nat Cell Biol 6: 443-450.
66. Li R, Waga S, Hannon GJ, Beach D, Stillman B. (1994). Nature 371: 534-537.
67. Li X, Dumont P, Della Pietra A, Shetler C, Murphy ME. (2005). J Biol Chem 280: 24245-24251.
68. Li YJ, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R. (1995). Oncogene 10: 599-601.
69. Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH et al. (1997). Am J Pathol 150: 167-175.
70. Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M. (2001). Oncogene 20: 320-328.
71. Maga G, Hubscher U. (2003). J Cell Sci 116: 3051-3060.
72. Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R et al. (2000). Int J Cancer 87: 528-533.
73. Marchenko ND, Zaika A, Moll UM. (2000). J Biol Chem 275: 16202-16212.
74. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA et al. (2000). Nat Genet 25: 47-54.
75. Massague J. (2004). Nature 432: 298-306.
76. Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. (1987). Mol Cell Biol 7: 961-963.
77. McKenzie KE, Siva A, Maier S, Runnebaum IB, Seshadri R, Sukumar S. (1997). Clin Cancer Res 3: 1669-1673.
78. Milner BJ, Hosking L, Sun S, Haites NE, Foulkes WD. (1996). Eur J Cancer 32A: 2360-2363.
79. Mitra S, Misra C, Singh RK, Panda CK, Roychoudhury S. (2005). J Clin Pathol 58: 26-31.
80. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. (1995). Hum Mol Genet 4: 1089-1092.
81. Nelson HH, Wilkojmen M, Marsit CJ, Kelsey KT. (2005). Carcinogenesis 26: 1770-1773.
82. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. (2000). Cell 102: 849-862.
83. Ohayon T, Gershoni-Baruch R, Papa MZ, Distelman Menachem T, Eisenberg Barzilai S, Friedman E. (2005). Br J Cancer 92: 1144-1148.
84. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y et al. (2001). Mol Cell 8: 85-94.
85. Olivier M, Eclcs R, Hollstein M, Khan MA, Harris CC, Hainaut P. (2002). Hum Mutat 19: 607-614.
86. Pegoraro RJ, Rom L, Lanning PA, Moodley M, Naiker S, Moodley J. (2002). Int J Gynecol Cancer 12: 383-388.
87. Phelps M, Darley M, Primrose JN, Blaydes JP. (2003). Cancer Res 63: 2616-2623.
88. Pim D, Banks L. (2004). Int J Cancer 108: 196-199.
89. Powell BL, van Staveren IL, Roosken P, Grieu F, Berns EM, Iacopetta B. (2002). Carcinogenesis 23: 311-315.
90. Ralhan R, Agarwal S, Mathur M, Wasylyk B, Srivastava A. (2000). Clin Cancer Res 6: 2440-2447.
91. Rodrigues FC, Kawasaki-Oyama RS, Fo JF, Ukuyama EE, Antonio JR, Bozola AR et al. Cancer Genet Cytogenet 142: 92-98.
92. Roh JW, Kim JW, Park NH, Song YS, Park IA, Park SY et al. (2004). Gynecol Oncol 93: 499-505.
93. Roh JW, Kim MH, Kim JW, Park NH, Song YS, Kang SB et al. (2001). Cancer Lett 165: 59-62.
94. Runnebaum IB, Tong XW, Konig R, Zhao H, Korner K, Atkinson EN et al. (1995). Lancet 345: 994. Erratum in: Lancet 345, 1250.
95. Sakamuro D, Sabbatini P, White E, Prendergast GC. (1997). Oncogene 15: 887-898.
96. Sanchez-Prieto R, Rojas JM, Taya Y, Gutkind JS. (2000). Cancer Res 60: 2464-2472.
97. Schuler M, Green DR. (2005). Trends Genet 21: 182-187.
98. Shen H, Liu Z, Strom SS, Spitz MR, Lee JE, Gershenwald JE et al. (2003). J Invest Dermatol 121: 1510-1514.
99. Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L et al. (2004). Oncol Rep 11: 1115-1120.
100. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. (2002). Cancer Lett 183: 123-130.
101. Shi Y, Zou M, Farid NR, al-Sedairy ST. (1996). Br J Cancer 74: 1336-1341.
102. Shih CM, Lin PT, Wang HC, Huang WC, Wang YC. (2000). Jpn J Cancer Res 91: 9-15.
103. Shiohara M, el-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R et al. (1994). Blood 84: 3781-3784.
104. Sjalander A, Birgander R, Kivela A, Beckman G. (1995). Hum Hered 45: 144-149.
105. Sjalander A, Birgander R, Rannug A, Alexandrie AK, Tornling G, Beckman G. (1996). Hum Hered 46: 221-225.
106. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. (2002). Cancer Lett 179: 175-183.
107. Sourvinos G, Rizos E, Spandidos DA. (2001). Oral Oncol 37: 572-578.
108. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F et al. (1998). Nature 393: 229-234.
109. Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S et al. (2003a). Cancer Epidemiol Biomarkers Prev 12: 174-175.
110. Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W et al. (2003b). Lung Cancer 40: 259-266.
111. Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M et al. (2004). Oncogene 23: 3328-3337.
112. Sun Y, Hildesheim A, Li H, Li Y, Chen JY, Cheng YJ et al. (1995). Cancer Epidemiol Biomarkers Prev 4: 261-267.
113. Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H et al. (2003). J Biomed Sci 10: 430-435.
114. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H et al. (2000). EMBO J 19: 6517-6526.
115. Terry LA, Boyd J, Alcorta D, Lyon T, Solomon G, Hannon G et al. (1996). Mol Carcinog 16: 221-228.
116. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. (1999). Mol Cell Biol 19: 1092-1100.
117. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. (2003). Cancer Lett 198: 69-75.
118. Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J et al. (2005). Clin Cancer Res 11: 5098-5103.
119. Tsai MH, Chen WC, Tsai FJ. (2002a). J Clin Lab Anal 16: 146-150.
120. Tsai MH, Lin CD, Hsieh YY, Chang FC, Tsai FJ, Chen WC et al. (2002b). Laryngoscope 112: 116-119.
121. Vikhanskaya F, Siddique MM, Kei Lee M, Broggini M, Sabapathy K. (2005). Clin Cancer Res 11: 4348-4356.
122. Waga S, Hannon GJ, Beach D, Stillman B. (1994). Nature 369: 574-578.
123. Walker KK, Levine AJ. (1996). Proc Natl Acad Sci USA 93: 15335-15340.
124. Wan M, Cofer KF, Dubeau L. (1996). Br J Cancer 73: 1398-1400.
125. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. (1999). Clin Cancer Res 5: 129-134.
126. Wang-Gohrke S, Weikel W, Risch H, Vesprini D, Abrahamson J, Lerman C et al. (1999). Br J Cancer 81: 179-183.
127. Weston A, Godbold JH. (1997). Environ Health Perspect 4: 919-926.
128. Wu MT, Chen MC, Wu DC. (2004). Cancer Lett 205: 61-68.
129. Wu MT, Wu DC, Hsu HK, Kao EL, Yang CH, Lee JM. (2003). Cancer Lett 201: 175-180.
130. Wu X, Zhao H, Amos CI, Shete S, Makan N, Hong WK et al. (2002). J Natl Cancer Inst 94: 681-690.
131. Xi YG, Ding KY, Su XL, Chen DF, You WC, Shen Y et al. (2004). Carcinogenesis 25: 2201-2206.
132. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. (1993). Nature 366: 701-704.
133. Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z et al. (2005). Clin Cancer Res 11: 7328-7333.
134. Zhang JH, Li Y, Wang R, Wen DG, Wu ML, He M. (2003). Zhonghua Zhong Liu Za Zhi 25: 365-367. (Chinese).